Dermatology · Burbank, CA
NPI
1043228083
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2720 W Magnolia Blvd
Burbank, CA, 91505
Phone (818) 842-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
22,350 services
Medicare patients, 2024
5,500
Average age 75
Drug cost, 2024
$945K
1,851 prescriptions
Company payments, 2025
$4,321
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manjunath S Vadmal was code 88305 (surgical pathology examination), 8,802 times for 4,679 patients. In total Manjunath S Vadmal billed 22,350 services in 92 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 8,802 | 4,679 | $58.75 | $517K |
| 17003 Destruction Skin Lesion | Office | 5,643 | 623 | $5.85 | $33K |
| 99213 Office E&M - Established | Office | 1,623 | 915 | $68.04 | $110K |
| 17000 Destruction Skin Lesion | Office | 1,098 | 685 | $37.57 | $41K |
| 11102 Skin Biopsy | Office | 752 | 573 | $65.62 | $49K |
| 17110 Destruction Skin Lesion | Office | 703 | 513 | $90.76 | $64K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 400 | 89 | $0.61 | $243 |
| 17004 Destruction Skin Lesion | Office | 389 | 259 | $140.29 | $55K |
| 11103 Skin Biopsy | Office | 368 | 242 | $44.13 | $16K |
| 88304 Surgical Pathology Examination | Office | 351 | 313 | $38.38 | $13K |
| 99214 Office E&M - Established | Office | 319 | 216 | $96.49 | $31K |
| 99203 Office E&M - New | Office | 226 | 226 | $74.96 | $17K |
| 99212 Office E&M - Established | Office | 218 | 174 | $41.56 | $9,060 |
| 88312 Surgical Pathology Examination | Office | 180 | 148 | $99.70 | $18K |
| 88341 Immunohistochemistry | Office | 148 | 48 | $80.17 | $12K |
By year: 2022 $446K for 11,183 services; 2023 $576K for 13,663 services; 2024 $1.1M for 22,350 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 8,802 | 4,679 | $58.75 | $517K |
| 88304 Surgical Pathology Examination | 351 | 313 | $38.38 | $13K |
| 88312 Surgical Pathology Examination | 180 | 148 | $99.70 | $18K |
| 88341 Immunohistochemistry | 148 | 48 | $80.17 | $12K |
| 88342 Immunohistochemistry | 74 | 66 | $93.26 | $6,901 |
| 88307 Surgical Pathology Examination | 32 | 31 | $248.72 | $7,959 |
| 88309 Surgical Pathology Examination | 22 | 21 | $379.46 | $8,348 |
| 88313 Surgical Pathology Examination | 15 | 14 | $75.59 | $1,134 |
Medicare prescription drug claims, 2024
In 2024, the drug Manjunath S Vadmal prescribed most often to Medicare patients was Ketoconazole, with 259 prescriptions and refills. In total Manjunath S Vadmal wrote 1,851 Medicare prescriptions that cost $945K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 259 | 281 | 139 | $3,900 |
| Clobetasol Propionate Generic | 157 | 165 | 105 | $15K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 132 | 150 | 91 | $5,257 |
| Triamcinolone Acetonide Generic | 108 | 133 | 71 | $1,343 |
| Desonide Generic | 66 | 68 | 54 | $2,729 |
| Doxycycline Hyclate Generic | 61 | 70 | 34 | $648 |
| Mupirocin Generic | 60 | 60 | 51 | $332 |
| Ammonium Lactate Generic | 59 | 63 | 34 | $1,059 |
| Tacrolimus Generic | 51 | 53 | 32 | $9,205 |
| Doxepin Hcl Generic | 46 | 54 | Under 11 | $501 |
| Clindamycin Phosphate Generic | 44 | 44 | 29 | $2,325 |
| Minoxidil Generic | 43 | 110 | 19 | $471 |
| Hydroxyzine Hcl Generic | 42 | 46 | 20 | $450 |
| Vtama Tapinarof | 38 | 40 | 21 | $52K |
| Ciclopirox Generic | 37 | 37 | 16 | $664 |
Brand drugs: 233 claims; generic drugs: 1,618 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manjunath S Vadmal $4,321 ($4,321 in general payments such as food, travel and fees) from 25 companies. The largest payer was LEO Pharma Inc. with $503.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 20 | $503 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $475 |
| Galderma Laboratories, L.P. GALD.SW | 38 | $455 |
| Genzyme Corporation SNY | 11 | $432 |
| Abbvie Inc. ABBV | 23 | $368 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 18 | $336 |
| Pfizer Inc. PFE | 27 | $316 |
| UCB, Inc. UCB.BR | 10 | $248 |
| Organon LLC OGN | 13 | $221 |
| Incyte Corporation INCY | 12 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.